Cargando…
Platelets upregulate tumor cell programmed death ligand 1 in an epidermal growth factor receptor-dependent manner in vitro
Programmed death ligand 1 (PD-L1) is an immune checkpoint protein that suppresses cytotoxic T lymphocytes and is often overexpressed in cancers. Due to favorable clinical trial results, immune checkpoint inhibition (ICI) is part of Food and Drug Administration approved immuno-oncology therapies; how...
Autores principales: | Guo, Qiuchen, Malloy, Michael W., Roweth, Harvey G., McAllister, Sandra S., Italiano, Joseph E., Battinelli, Elisabeth M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The American Society of Hematology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9582587/ https://www.ncbi.nlm.nih.gov/pubmed/35482455 http://dx.doi.org/10.1182/bloodadvances.2021006120 |
Ejemplares similares
-
Pro-inflammatory megakaryocyte gene expression in murine models of breast cancer
por: Roweth, Harvey G., et al.
Publicado: (2022) -
Lessons to learn from tumor-educated platelets
por: Roweth, Harvey G., et al.
Publicado: (2021) -
Live imaging of platelets and neutrophils during antibody-mediated neurovascular thrombosis
por: Laroche, Audree, et al.
Publicado: (2022) -
Dissecting platelet proteomics to understand the pathophysiology of immune thrombocytopenia: studies in mouse models
por: Martínez-Botía, Patricia, et al.
Publicado: (2022) -
Gilteritinib-induced upregulation of S100A9 is mediated through BCL6 in acute myeloid leukemia
por: Zavorka Thomas, Megan E., et al.
Publicado: (2021)